4.8 Article

Ebola haemorrhagic fever

期刊

LANCET
卷 377, 期 9768, 页码 849-862

出版社

ELSEVIER SCIENCE INC
DOI: 10.1016/S0140-6736(10)60667-8

关键词

-

资金

  1. Canadian Institutes of Health Research (CIHR)
  2. Division of Intramural Research (DIR)
  3. National Institutes of Allergy and Infectious Diseases (NIAID)
  4. National Institutes of Health (NIH)
  5. Public Health Agency of Canada (PHAC)
  6. Defense Threat Reduction Agency

向作者/读者索取更多资源

Ebola viruses are the causative agents of a severe form of viral haemorrhagic fever in man, designated Ebola haemorrhagic fever, and are endemic in regions of central Africa. The exception is the species Reston Ebola virus, which has not been associated with human disease and is found in the Philippines. Ebola virus constitutes an important local public health threat in Africa, with a worldwide effect through imported infections and through the fear of misuse for biological terrorism. Ebola virus is thought to also have a detrimental effect on the great ape population in Africa. Case-fatality rates of the African species in man are as high as 90%, with no prophylaxis or treatment available. Ebola virus infections are characterised by immune suppression and a systemic inflammatory response that causes impairment of the vascular, coagulation, and immune systems, leading to multiorgan failure and shock, and thus, in some ways, resembling septic shock.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据